Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pasireotide in Recurrent or Progressive Meningioma
NCT00813592Phase 2Terminated
- Sponsor
- University of Utah
- Start
- Nov 2008
- Primary completion
- Mar 2013
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pasireotide LAR in meningioma, sponsored by University of Utah. Started Nov 2008; status: terminated.
02
Drugs
pasireotide LAR
03
Conditions
meningioma
Beyond the preview
Go deeper on NCT00813592.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00813592.